Patients taking MTX were randomized ( @:@:@ ) to receive fostamatinib @ mg twice daily for @ weeks ( group A ) , fostamatinib @ mg twice daily for @ weeks and then @ mg once daily ( group B ) , or placebo for @ weeks and then fostamatinib @ mg twice daily ( group C ) .